CSIMarket Company Name, Ticker, Industry, else..


Quest Diagnostics Inc  (NYSE: DGX)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Quest Diagnostics Inc

DGX's Fundamental analysis



Looking into Quest Diagnostics Inc growth rates, revenue grew by 12.09 % in I. Quarter 2025 from the same quarter a year ago. Ranking at No. 183

Medical Laboratories industry recorded growth of revenues by 11.59 %

Quest Diagnostics Inc's net income grew by 12.98 % in I. Quarter 2025 year on year, above company average,

• More on DGX's Growth


Quest Diagnostics Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Quest Diagnostics Inc PEG ratio is at 3.43 Quest Diagnostics Inc realized cash reduction of $ -2.53 per share in trailing twelve-month period.
Company
22.02
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.93.
Medical Laboratories industry's Price to Sales ratio is at 2.17.


• More on DGX's Valuation
 
 Total Debt (Millions $) 5,859
 Dividend TTM ($) 2.98 $
 Dividend Yield TTM (%) 1.71 %
 Revenue/Employee (TTM) $ 211,625
 Net Income/Employee (TTM) $ 19,750
 Receivable Turnover (TTM) 7.52
 Tangible Book Value (Per Share $) -31.96

Quest Diagnostics Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Quest Diagnostics Inc PEG ratio is at 3.43 Quest Diagnostics Inc realized cash outflow of $ -2.53per share in trailing twelve-month period.
Company
22.02
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.93.
Medical Laboratories industry's Price to Sales ratio is at 2.17.

Quest Diagnostics Inc Price to Book Ratio is at 2.82 lower than Industry Avg. of 147.07. and higher than S&P 500 Avg. of 0.01

• More on DGX's Valuation

•  Market Capitalization (Millions $) 19,635
•  Shares Outstanding (Millions) 113
•  Employees 48,000
•  Revenues (TTM) (Millions $) 10,158
•  Net Income (TTM) (Millions $) 948
•  Cash Flow (TTM) (Millions $) -286
•  Capital Exp. (TTM) (Millions $) -438
•  Total Debt (Millions $) 5,859
•  Dividend TTM ($) 2.98 $
•  Dividend Yield TTM (%) 1.71 %
•  Revenue/Employee (TTM) $ 211,625
•  Net Income/Employee(TTM) $ 19,750
•  Receivable Turnover Ratio (TTM) 7.52
•  Tangible Book Value (Per Share $) -31.96

•  Market Capitalization (Millions $) 19,635
•  Shares Outstanding (Millions) 113
•  Employees 48,000
•  Revenues (TTM) (Millions $) 10,158
•  Net Income (TTM) (Millions $) 948
•  Cash Flow (TTM) (Millions $) -286
•  Capital Exp. (TTM) (Millions $) -438


    DGX's Profitability Comparisons
Quest Diagnostics Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in I. Quarter 2025 to 13.05 % from 13.77 % in IV. Quarter.

Quest Diagnostics Inc net profit margin of 8.86 % is currently ranking no. 2 in Medical Laboratories industry, ranking no. 10 in Healthcare sector and number 137 in S&P 500.


Profitability by Segment
Total 8.86 %



  Ratio
•   Capital Ratio (MRQ) 1.64
•  Total Debt to Equity (MRQ) 0.84
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.68
•  Inventory Turnover Ratio (TTM) 36.73



Quest Diagnostics Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in I. Quarter 2025 to 13.05 % from 13.77 % in IV. Quarter.

Quest Diagnostics Inc net profit margin of 8.86 % is currently ranking no. 2 in Medical Laboratories industry, ranking no. 10 in Healthcare sector and number 137 in S&P 500.

• More on DGX's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com